Company intelligence / Profile preview

Aescap

Amsterdam, North Holland, Netherlandsaescap.com ↗

Ownership: Private
Development stage: Other

Overview

Aescap is a specialist investment firm managing funds that invest in publicly traded and innovative biotech/life sciences companies developing next-generation medicines. Their funds focus on high-growth opportunities in biopharmaceuticals—including gene therapies, RNA therapies, cell therapies—and target diseases with significant unmet medical needs. They are known for deep sector expertise and active engagement with their portfolio.

Modalities: Small molecule (via portfolio companies)Monoclonal antibody (via portfolio companies)Gene therapy (via portfolio companies)RNA therapy (via portfolio companies)Cell therapy (via portfolio companies)
Industry: Investors

Beyond the preview

Go deeper on Aescap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aescap.

Explore the full profile